These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5388434)

  • 1. [Treatment of malignant tumor with bleomycin, with special reference to lung cancer, malignant lymphoma and leukemia].
    Hiraki K; Kimura I
    Nihon Ishikai Zasshi; 1969 Jul; 62(2):173-8. PubMed ID: 5388434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of malignant tumors with bleomycin--therapeutic application in the field of internal medicine].
    Kimura I; Onoshi T; Takata H; Nishizaki Y; Shirai K
    Naika; 1970 Feb; 25(2):317-28. PubMed ID: 5438417
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of malignant lymphoma, with special reference to the effect of bleomycin].
    Kimura K; Sakai Y; Konda C; Kashiwada N; Kitahara T
    Nihon Rinsho; 1969 Jun; 27(6):1593-601. PubMed ID: 5816829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of Bleomycin in tumor pateints].
    Rieche K; Matthias M
    Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of a cooperative clinical study of the new antineoplastic antibiotic rubomycin].
    Kachalov VK; Blokhina NG; Garin AM; Gershanovich ML; Kovaleva LG
    Antibiotiki; 1969 Dec; 14(12):1059-63. PubMed ID: 4313308
    [No Abstract]   [Full Text] [Related]  

  • 6. [New antineoplastic agent, bleomycin, with special reference to its notable effect on squamous cell carcinoma].
    Ichikawa T
    Nihon Rinsho; 1969 Jun; 27(6):1618-26. PubMed ID: 5816830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
    Clavel B
    Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of lung tumor with bleomycin].
    Oka S
    Nihon Ishikai Zasshi; 1969 Jul; 62(2):126-36. PubMed ID: 5388428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
    Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A phase II clinical trial of pepleomycin].
    Feng F; Zhang H
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):388-91. PubMed ID: 9387284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.
    Green MR; Vosika G; Propert KJ; Ware JH; Comis R
    Cancer Treat Rep; 1986 Apr; 70(4):539-40. PubMed ID: 3698052
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of lung cancer with bleomycin.
    Oka S; Sato K; Nakai Y; Kurita K; Hashimoto K; Oshibe M
    Sci Rep Res Inst Tohoku Univ Med; 1969 Oct; 16(1):30-6. PubMed ID: 5375996
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with pepleomycin].
    Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
    Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
    Lopez M; Di Lauro L; Papaldo P; Lazzaro B
    Clin Ter; 1984 Apr; 109(1):31-5. PubMed ID: 6233078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic and side effects of bleomycin, with special reference to histopathological study of the lung. 1. Therapeutic effects of bleomycin in cancer].
    Okamura A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1973 May; 11(5):270-7. PubMed ID: 4125908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined therapy of multiple antibiotics for malignant tumors (METT-therapy)].
    Ota K; Kurita S; Nishimura M; Sugiyama Y; Ogawa M
    Saishin Igaku; 1968 Mar; 23(3):631-45. PubMed ID: 4971779
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rubidomycine. A new antineoplastic antibiotic].
    Soulié L
    Munch Med Wochenschr; 1968 Jun; 110(25):1539-41. PubMed ID: 5252222
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of advanced non-small cell lung cancer with bisantrene.
    Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
    Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
    Myers JW; Von Hoff DD; Clark GM; Coltman CA
    Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of lung cancer (especially small-sized) with Bleomycin--significance of CPBP therapy].
    Kimura I; Moritani Y; Onoshi T; Takata H; Kunimasa I
    Gan No Rinsho; 1970; 16(12):1161-70. PubMed ID: 5531009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.